ES2165441T3 - Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos. - Google Patents
Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos.Info
- Publication number
- ES2165441T3 ES2165441T3 ES95943478T ES95943478T ES2165441T3 ES 2165441 T3 ES2165441 T3 ES 2165441T3 ES 95943478 T ES95943478 T ES 95943478T ES 95943478 T ES95943478 T ES 95943478T ES 2165441 T3 ES2165441 T3 ES 2165441T3
- Authority
- ES
- Spain
- Prior art keywords
- catepsin
- inhibitors
- calpain
- oxazolidin
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ESTA INVENCION TRATA DE INHIBIDORES DE OXAZOLIDINA DE CALPAINA Y/O DE CATEPSINA B, Y DE COMPOSICIONES QUE LOS CONTIENEN. COMO INHIBIDORES DE CALPAINA Y/O DE CATEPSINA B, LOS COMPUESTOS RESULTAN UTILES PARA EL TRATAMIENTO DE PACIENTES QUE SUFREN TRASTORNOS NEURODEGENERATIVOS AGUDOS O CRONICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37119295A | 1995-01-11 | 1995-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2165441T3 true ES2165441T3 (es) | 2002-03-16 |
Family
ID=23462894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95943478T Expired - Lifetime ES2165441T3 (es) | 1995-01-11 | 1995-12-15 | Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos. |
Country Status (23)
Country | Link |
---|---|
US (1) | US5691368A (es) |
EP (1) | EP0802909B1 (es) |
JP (1) | JP4157601B2 (es) |
KR (1) | KR100393701B1 (es) |
CN (1) | CN1088456C (es) |
AR (1) | AR001787A1 (es) |
AT (1) | ATE206413T1 (es) |
AU (1) | AU692044B2 (es) |
CA (1) | CA2210258C (es) |
DE (1) | DE69523072T2 (es) |
DK (1) | DK0802909T3 (es) |
ES (1) | ES2165441T3 (es) |
FI (1) | FI972935A (es) |
HU (1) | HUT77649A (es) |
IL (1) | IL116724A (es) |
MX (1) | MX9705235A (es) |
NO (1) | NO309267B1 (es) |
NZ (1) | NZ298999A (es) |
PT (1) | PT802909E (es) |
SI (1) | SI0802909T1 (es) |
TW (1) | TW454001B (es) |
WO (1) | WO1996021655A2 (es) |
ZA (1) | ZA96100B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1270882B (it) * | 1993-10-05 | 1997-05-13 | Isagro Srl | Oligopeptidi ad attivita' fungicida |
US5925633A (en) * | 1996-03-06 | 1999-07-20 | Synphar Laboraties, Inc. | 3-Substituted-4-oxa-1-azabicyclo 3,2,0!heptan-7-one as cysteine protease inhibitors |
AU6134498A (en) * | 1997-03-07 | 1998-09-22 | Hoechst Marion Roussel, Inc. | Method of treating trauma associated with brain, spinal cord or peripheral nerveinjury using carbobenzyloxy n-protected di- and tripeptide phenylalaninals |
WO2000021550A2 (en) * | 1998-10-13 | 2000-04-20 | President And Fellows Of Harvard College | Methods and compositions for treating neurodegenerative diseases |
CA2350133A1 (en) * | 1998-11-12 | 2000-05-18 | Research Corporation Technologies, Inc. | A method for treating tissue damaged from ischemia |
EP1159273A1 (en) * | 1999-03-02 | 2001-12-05 | Boehringer Ingelheim Pharmaceuticals Inc. | Compounds useful as reversible inhibitors of cathepsin s |
TW200404789A (en) * | 1999-03-15 | 2004-04-01 | Axys Pharm Inc | Novel compounds and compositions as protease inhibitors |
EP1516877A1 (en) * | 1999-03-15 | 2005-03-23 | Axys Pharmaceuticals, Inc. | Amine derivatives as protease inhibitors |
US6506733B1 (en) | 1999-03-15 | 2003-01-14 | Axys Pharmaceuticals, Inc. | Compounds and compositions as protease inhibitors |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
FR2800737B1 (fr) * | 1999-11-05 | 2006-06-30 | Sod Conseils Rech Applic | Nouveaux composes heterocycliques et leur application a titre de medicaments |
CA2389685C (fr) * | 1999-11-05 | 2011-07-12 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R) | Nouveaux composes heterocycliques et leur application a titre de medicaments |
CA2417744A1 (en) * | 2000-07-31 | 2002-02-07 | The Regents Of The University Of California | Model for alzheimer's disease and other neurodegenerative diseases |
JP2004523506A (ja) | 2000-12-22 | 2004-08-05 | アクシス・ファーマシューティカルズ・インコーポレイテッド | カテプシン阻害剤としての新規な化合物と組成物 |
US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
MXPA04002282A (es) | 2001-09-14 | 2005-03-07 | Axis Pharmaceutical Inc | Nuevos compuestos y preparaciones como inhibidores de la catepsina. |
RU2004117877A (ru) | 2001-11-14 | 2006-01-10 | Авентис Фармасьютикалз Инк. (Us) | Олигопептиды и композиции, содержащие их, в качестве ингибиторов катепсина s |
WO2004084830A2 (en) * | 2003-03-21 | 2004-10-07 | Buck Institute | Method for treating alzheimer’s dementia |
US7384970B2 (en) * | 2003-03-24 | 2008-06-10 | Irm Llc | Inhibitors of cathepsin S |
US7109243B2 (en) * | 2003-03-24 | 2006-09-19 | Irm Llc | Inhibitors of cathepsin S |
WO2004089395A2 (en) * | 2003-04-01 | 2004-10-21 | Aventis Pharmaceuticals Inc. | Use of an inhibitor of cathepsin-s or -b to treat or prevent chronic obstructive pulmonary disease |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
US7173051B2 (en) * | 2003-06-13 | 2007-02-06 | Irm, Llc | Inhibitors of cathepsin S |
US7256207B2 (en) * | 2003-08-20 | 2007-08-14 | Irm Llc | Inhibitors of cathepsin S |
FR2863268B1 (fr) * | 2003-12-09 | 2006-02-24 | Sod Conseils Rech Applic | Nouveaux derives du 2-hydroxytetrahydrofuranne et leur application a titre de medicaments |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
CA2679446C (en) | 2007-03-01 | 2016-05-17 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CA2729780A1 (en) * | 2008-07-03 | 2010-01-07 | University Of Massachusetts | Methods and compositions for reducing inflammation and treating inflammatory disorders |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤 |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
WO2024018245A1 (en) | 2022-07-22 | 2024-01-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of calpain inhibitors for the treatment of the diabetic kidney disease |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867364A (en) * | 1968-11-21 | 1975-02-18 | Microbial Chem Res Found | Process for the synthesis of leupeptins and their analogues |
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US4277395A (en) * | 1980-06-16 | 1981-07-07 | Richardson-Merrell Inc. | Novel enzyme inhibitors |
JPS5754157A (en) * | 1980-09-19 | 1982-03-31 | Nippon Kayaku Co Ltd | L-argininal derivative and its preparation |
US4535167A (en) * | 1981-12-14 | 1985-08-13 | Merck & Co. Inc. | Chiral, N-protected, N-substituted α-amino acids |
GB2124233B (en) * | 1982-07-19 | 1985-09-18 | Nat Res Dev | Synthetic peptides and their preparation |
US5091575A (en) * | 1985-01-23 | 1992-02-25 | Abbott Laboratories | Peptidylaminodiols |
US4845079A (en) * | 1985-01-23 | 1989-07-04 | Luly Jay R | Peptidylaminodiols |
US5214129A (en) * | 1985-01-23 | 1993-05-25 | Abbott Laboratories | Peptidylaminodiols |
US5496927A (en) * | 1985-02-04 | 1996-03-05 | Merrell Pharmaceuticals Inc. | Peptidase inhibitors |
JPH079705B2 (ja) * | 1986-05-28 | 1995-02-01 | オリンパス光学工業株式会社 | 光カ−ド用デ−タ記録再生装置 |
US4851387A (en) * | 1986-10-14 | 1989-07-25 | Banyu Pharmaceutical Co., Ltd. | 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use |
US5032577A (en) * | 1986-12-31 | 1991-07-16 | Abbott Laboratories | Peptidylaminodiols |
NZ223148A (en) * | 1987-01-16 | 1989-10-27 | Merrell Dow Pharma | Peptide derivatives having peptidase inhibition activity |
US4820691A (en) * | 1987-06-24 | 1989-04-11 | E. R. Squibb & Sons, Inc. | Amino acid 1,2-diketo derivatives as renin inhibitors |
EP0313847A3 (en) * | 1987-10-01 | 1989-11-29 | G.D. Searle & Co. | Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents |
EP0329295A1 (en) * | 1988-02-01 | 1989-08-23 | The Upjohn Company | Renin inhibiting peptides with polar end groups |
WO1990000399A1 (en) * | 1988-07-08 | 1990-01-25 | Smithkline Beckman Corporation | Retroviral protease binding peptides |
ZA897515B (en) * | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
US4990525A (en) * | 1988-12-22 | 1991-02-05 | Rohm And Haas Company | Synergistic microbicidal combinations containing 3-isothiazolone and commerical biocides |
JP2701932B2 (ja) * | 1989-04-10 | 1998-01-21 | サントリー株式会社 | タンパク質分解酵素阻害剤 |
US5510531A (en) * | 1989-04-10 | 1996-04-23 | Suntory Limited | Proteinase inhibitor |
CA2032259A1 (en) * | 1989-12-18 | 1991-06-19 | Wayne J. Thompson | Hiv protease inhibitors useful for the treatment of aids |
HU9203505D0 (en) * | 1990-06-01 | 1993-01-28 | Du Pont Merck Pharma | 1,4-diamino-2,3-dihydroxi-butane compounds |
DE4037437A1 (de) * | 1990-11-24 | 1992-05-27 | Hoechst Ag | Aminodiol-derivate |
JPH06504061A (ja) * | 1990-12-28 | 1994-05-12 | コーテックス ファーマシューティカルズ インコーポレイテッド | 神経変性の治療および予防におけるカルパイン阻害剤の使用 |
CA2098702A1 (en) * | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
US5444042A (en) * | 1990-12-28 | 1995-08-22 | Cortex Pharmaceuticals | Method of treatment of neurodegeneration with calpain inhibitors |
CA2071621C (en) * | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
JP3190431B2 (ja) * | 1991-07-01 | 2001-07-23 | 三菱化学株式会社 | ケトン誘導体 |
ZA926185B (en) * | 1991-08-22 | 1993-03-01 | Merrell Dow Pharma | Novel orally-active elastase inhibitors. |
EP0580161A1 (en) * | 1992-07-22 | 1994-01-26 | THE McLEAN HOSPITAL CORPORATION | Prophylactic and therapeutic treatment of Alzheimer's disease |
DK0603769T3 (da) * | 1992-12-25 | 1999-06-14 | Mitsubishi Chem Corp | Alfa-aminoketonderivater |
JP2848232B2 (ja) * | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | アルデヒド誘導体 |
US5541290A (en) * | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
WO1995009838A1 (en) * | 1993-10-01 | 1995-04-13 | Merrell Pharmaceuticals Inc. | INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
-
1995
- 1995-12-11 US US08/552,139 patent/US5691368A/en not_active Expired - Lifetime
- 1995-12-15 AT AT95943478T patent/ATE206413T1/de not_active IP Right Cessation
- 1995-12-15 DE DE69523072T patent/DE69523072T2/de not_active Expired - Lifetime
- 1995-12-15 CN CN95197320A patent/CN1088456C/zh not_active Expired - Fee Related
- 1995-12-15 AU AU44731/96A patent/AU692044B2/en not_active Ceased
- 1995-12-15 PT PT95943478T patent/PT802909E/pt unknown
- 1995-12-15 ES ES95943478T patent/ES2165441T3/es not_active Expired - Lifetime
- 1995-12-15 WO PCT/US1995/016565 patent/WO1996021655A2/en active IP Right Grant
- 1995-12-15 EP EP95943478A patent/EP0802909B1/en not_active Expired - Lifetime
- 1995-12-15 JP JP52166996A patent/JP4157601B2/ja not_active Expired - Lifetime
- 1995-12-15 HU HU9800041A patent/HUT77649A/hu unknown
- 1995-12-15 SI SI9530539T patent/SI0802909T1/xx unknown
- 1995-12-15 DK DK95943478T patent/DK0802909T3/da active
- 1995-12-15 NZ NZ298999A patent/NZ298999A/xx unknown
- 1995-12-15 CA CA002210258A patent/CA2210258C/en not_active Expired - Lifetime
- 1995-12-15 MX MX9705235A patent/MX9705235A/es unknown
- 1995-12-15 KR KR1019970704709A patent/KR100393701B1/ko not_active IP Right Cessation
-
1996
- 1996-01-08 ZA ZA96100A patent/ZA96100B/xx unknown
- 1996-01-09 IL IL11672496A patent/IL116724A/xx not_active IP Right Cessation
- 1996-01-09 AR AR33495896A patent/AR001787A1/es unknown
- 1996-01-10 TW TW085100250A patent/TW454001B/zh not_active IP Right Cessation
-
1997
- 1997-07-10 FI FI972935A patent/FI972935A/fi not_active IP Right Cessation
- 1997-07-10 NO NO973216A patent/NO309267B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2210258A1 (en) | 1996-07-18 |
DE69523072D1 (en) | 2001-11-08 |
FI972935A0 (fi) | 1997-07-10 |
KR100393701B1 (ko) | 2003-11-28 |
AU4473196A (en) | 1996-07-31 |
EP0802909A2 (en) | 1997-10-29 |
DE69523072T2 (de) | 2002-06-20 |
SI0802909T1 (en) | 2002-02-28 |
AU692044B2 (en) | 1998-05-28 |
IL116724A (en) | 2000-08-31 |
CA2210258C (en) | 2002-10-01 |
DK0802909T3 (da) | 2002-01-28 |
US5691368A (en) | 1997-11-25 |
NO309267B1 (no) | 2001-01-08 |
NZ298999A (en) | 1999-01-28 |
CN1173174A (zh) | 1998-02-11 |
NO973216L (no) | 1997-09-09 |
NO973216D0 (no) | 1997-07-10 |
JP4157601B2 (ja) | 2008-10-01 |
WO1996021655A2 (en) | 1996-07-18 |
FI972935A (fi) | 1997-07-10 |
JPH10512257A (ja) | 1998-11-24 |
TW454001B (en) | 2001-09-11 |
IL116724A0 (en) | 1996-05-14 |
ZA96100B (en) | 1996-07-24 |
PT802909E (pt) | 2002-03-28 |
EP0802909B1 (en) | 2001-10-04 |
HUT77649A (hu) | 1998-07-28 |
ATE206413T1 (de) | 2001-10-15 |
MX9705235A (es) | 1997-10-31 |
CN1088456C (zh) | 2002-07-31 |
WO1996021655A3 (en) | 1996-09-06 |
AR001787A1 (es) | 1997-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2165441T3 (es) | Inhibidores de calpaina y/o catepsina b oxazolidin sustituidos. | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
AR020021A1 (es) | Composicion para el tratamiento de cancer usando aceites esenciales de plantas naturales con moduladores de transduccion de senal | |
ES2181614T3 (es) | Sulfonilfenilheterociclos sustituidos como inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. | |
ES2139959T3 (es) | Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2. | |
UY29796A1 (es) | Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor | |
GT200500007A (es) | [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia. | |
CU23393A3 (es) | Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen | |
ECSP055738A (es) | PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL | |
ES2191152T3 (es) | Terapia combinada para el tratamiento de psicosis. | |
GT199700015A (es) | Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion. | |
ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
UY26130A1 (es) | Compuestos para tratar la obesidad | |
ES2115237T3 (es) | Fenil heterociclos como inhibidores de la ciclooxigenasa-2. | |
HN1998000157A (es) | Agonistas de prostaglandinas | |
PT1259512E (pt) | Compostos de pteridin para o tratamento da psoriase | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
ES2183937T3 (es) | Inhibidores de la adhesion celular. | |
ECSP044935A (es) | Inhibidores de la dipeptidil peptidasa beta-amino heterocíclica para el tratamiento o la prevención de la diabetes | |
CL2004000849A1 (es) | Compuestos derivados de benzamidas-2-hidroxi-3-diaminoalcanos, utiles para el tratamiento o la prevencion de alzheimer, sindrome de down, hemorragia cerebral hereditaria, demencias degenerativas y otras. | |
ES2058306T3 (es) | Tetralinas substituidas, cromanos y compuestos relacionados en el tratamiento del asma, artritis y enfermedades relacionadas. | |
PA8457001A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol | |
DE69825286D1 (de) | Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen | |
DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 802909 Country of ref document: ES |